Reckitt Benckiser to pay $1.4 billion in opioid treatment settlement

Buprenorphine is a opioid used as an alternative to methadone to help addicts recovering from heroin use. Buprenorphine is different from other opioids because it's a "partial opioid agonist," which means that when taken in proper prescribed doses, it should produce less euphoria and physical dependence, and therefore a lower potential for misuse. It's also supposed to have a relatively mild withdrawal profile. However, if abused by crushing and snorting or injecting, it can suppress breathing and cause dizziness, confusion, unconsciousness and death. Subutex, the brand name for buprenorphine, is taken as a tablet placed under the tongue and allowed to dissolve. The brand Suboxone is a combination of buprenorphine and naloxone, an opioid antagonist. Antagonists block the opiate receptors in the brain, keeping the narcotic from creating the high abusers crave.

Source: CNN

Powered by NewsAPI.org

Keywords:

Reckitt Benckiser • Opioid • Drug rehabilitation • Buprenorphine • Opioid • Alternative medicine • Methadone • Substance dependence • Heroin • Buprenorphine • Opioid • Partial agonist • Opioid • Agonist • Medical prescription • Dose (biochemistry) • Euphoria • Physical dependence • Action potential • Substance abuse • Drug withdrawal • Breathing • Dizziness • Confusion • Unconsciousness • Death • Buprenorphine • Brand • Buprenorphine • Tablet (pharmacy) • Sublingual administration • Buprenorphine/naloxone • Combination drug • Buprenorphine • Naloxone • Opioid antagonist • Opioid receptor • Brain • Narcotic • Substance intoxication •